The Europe surgical retractors market is projected to record a CAGR of 6.00% during the estimated period between 2022 and 2030, and is anticipated to be valued at $863.91 million by 2030.

The European market is expected to grow owing to the presence of strong research & academic bases and the availability of funding for research. Further, the European Research Council (ERC) provides scientific and technological research grants within the European Union (EU). Additionally, the surging geriatric population is prone to major complications and diseases, so it is expected to support surgical procedures in the region, thus encouraging the growth of surgical retractors. The market surge can also be attributed to the high adoption of advanced technologies, the prevalence of chronic disorders, the growing demand for minimally invasive procedures, and increasing reimbursement for surgical procedures.

To know more about this report, request a free sample copy

The Europe surgical retractors market growth assessment includes the analysis of Spain, Italy, United Kingdom, Nordic Countries,  France, Germany, and Rest of Europe. According to industry reports, over 10 million operations are performed annually in the United Kingdom. Additionally, NHS England data denotes that around 6.4 million people in the United Kingdom are waiting to start routine hospital treatment, including surgeries. Moreover, hernias, hip replacement, knee replacement, and gall bladder removal are the most common surgeries in the country. Therefore, a larger number of surgical procedures is expected to support the demand for surgical retractors.  

Furthermore, Germany spends the highest proportion of its wealth on health. In proportion to population, there are more hospital beds in Germany than in any other European country. Additionally, cardiovascular diseases and cancer cause nearly two-thirds of deaths in both men and women. Thus, factors such as greater health care spending and the growing prevalence of fatal diseases contribute to the expansion of the Germany surgical retractors market.

The Europe surgical retractors market assessment includes segmentation by application, end-user, and type. Market by application covers cardiothoracic surgery, neurosurgery, general surgery, obstetrics & gynecology, orthopedics, and other applications.

Obstetrics & gynecology is the area of medicine that deals with treating pregnant women before, during, and after childbirth. The primary goal of obstetrics is to protect and preserve a woman’s general health throughout her pregnancy. It includes pregnancy, labor, childbirth and the postpartum period. Gynecology emphasizes women’s reproductive health of women. It covers the diagnosis, treatment, and care of women’s reproductive system, which mainly includes the vagina, uterus, ovaries and fallopian tubes. Increasing obstetrics and gynecology procedures will encourage the growth of the Europe surgical retractors market.

Cardiothoracic surgery is the specialty that deals with cardiovascular (heart and blood vessel) surgery and pulmonary (lung) surgery. This surgery treats illnesses and traumatic injuries to the heart, lungs, and other structures such as the diaphragm, esophagus (feeding tube), and trachea (windpipe). Some common cardiothoracic surgeries and procedures include angioplasty, stent placement, open heart surgery etc. The rising need for cardiothoracic surgeries is anticipated to boost the market growth.

Leading companies operating in the Europe surgical retractors market include Medtronic PLC, B Braun Holding GmbH & Co KG, etc.

B Braun Holding GmbH & Co KG manufactures medical devices and pharmaceutical products. Their portfolio comprises over 5,000 products, including hip & knee implants, ostomy,  infusion pumps & systems, pharmaceuticals, suture materials, dialysis equipment & accessories, surgical instruments, and disinfection & wound care products. It serves customers such as medical practitioners, hospitals, pharmacies, emergency medical services, long-term care, etc. The company is headquartered in Melsungen, Germany and has business operations in Europe, North America, Asia-Pacific, and the Middle East & Africa. B Braun Holding is headquartered in Melsungen, Germany.

B Braun Holding’s leading product, the Frankfurt mini-retraction system, is made for use in thyroid and pediatric surgery.

Report Synopsis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.